Updated trends in imaging use in men diagnosed with prostate cancer
Cooperberg & the Urologic Disease of America Project (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 13, 2014 Category: Urology & Nephrology Authors: S P PortenA SmithA Y OdishoM S LitwinC S SaigalP R CarrollM R Cooperberg Source Type: research

Effectiveness of diet, sexual habits and lifestyle modifications on treatment of chronic pelvic pain syndrome
Prostate Cancer and Prostatic Diseases advance online publication, May 13 2014. doi:10.1038/pcan.2014.18 Author: L Gallo (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 13, 2014 Category: Urology & Nephrology Authors: L Gallo Source Type: research

Folate intake and the risk of prostate cancer: a systematic review and meta-analysis
G D Eslick (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 13, 2014 Category: Urology & Nephrology Authors: M TioJ AndriciM R CoxG D Eslick Source Type: research

Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review
llaudiére, P Richaud & A Fléchon (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 6, 2014 Category: Urology & Nephrology Authors: P SargosL FerrettiM Gross-GoupilM OrreF CornelisB Henriques de FigueiredoN HouédéC MerinoG RoubaudB DallaudiéreP RichaudA Fléchon Source Type: research

Comparison of outcomes after TURP versus photoselective vaporization of the prostate with respect to trainee involvement utilizing ACS NSQIP
mp; L P McMann (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 15, 2014 Category: Urology & Nephrology Authors: S P OlceseR DerosaS Q KernM B LustikJ R SterbisL P McMann Source Type: research

Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer
enfuss & J C Tilburt (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 8, 2014 Category: Urology & Nephrology Authors: S P KimC P GrossP Y NguyenM C SmaldoneR H ThompsonN D ShahA KutikovL C HanR J KarnesJ Y ZiegenfussJ C Tilburt Source Type: research

Prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study
p; E Finazzi-Agrò (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 1, 2014 Category: Urology & Nephrology Authors: A D AsimakopoulosD Del FabbroR MianoM SantonicoR CapuanoG PennazzaA D'AmicoE Finazzi-Agrò Source Type: research

Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis
J Epstein (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - April 1, 2014 Category: Urology & Nephrology Authors: D BrungsJ ChenP MassonR J Epstein Source Type: research

Novel bone-targeting agents in prostate cancer
M Hahn (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 25, 2014 Category: Urology & Nephrology Authors: C AlbanyN M Hahn Source Type: research

Ganglioside disialosyl globopentaosylceramide is an independent predictor of PSA recurrence-free survival following radical prostatectomy
S Saito & Y Arai (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 18, 2014 Category: Urology & Nephrology Authors: S ShimadaA ItoY KawasakiN KakoiT TaimaK MitsuzukaM WatanabeS SaitoY Arai Source Type: research

Androgen dynamics and serum PSA in patients treated with abiraterone acetate
her & A Molina (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 18, 2014 Category: Urology & Nephrology Authors: C J RyanW PengT KheohE WelkowskyC M HaqqD W ChandlerH I ScherA Molina Source Type: research

Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC)
G M Torres & A Berenguer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 11, 2014 Category: Urology & Nephrology Authors: M LujánA PáezJ C AnguloR GranadosM NevadoG M TorresA Berenguer Tags: prostate-specific antigen early detection of cancer mortality Source Type: research

A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study
A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer—the UK NCRN Pomi-T study Prostate Cancer and Prostatic Diseases advance online publication, March 11 2014. doi:10.1038/pcan.2014.6 Authors: R Thomas, M Williams, H Sharma, A Chaudry & P Bellamy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 11, 2014 Category: Urology & Nephrology Authors: R ThomasM WilliamsH SharmaA ChaudryP Bellamy Tags: nutrition active surveillance watchful waiting Source Type: research

A risk-adjusted definition of biochemical recurrence after radical prostatectomy
ll & D W Lin (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 11, 2014 Category: Urology & Nephrology Authors: T M MorganM V MengM R CooperbergJ E CowanV WeinbergP R CarrollD W Lin Tags: biochemical recurrence radical prostatectomy risk stratification Source Type: research

The role of transperineal template prostate biopsies in prostate cancer diagnosis in biopsy naïve men with PSA less than 20 ng ml−1
The role of transperineal template prostate biopsies in prostate cancer diagnosis in biopsy naïve men with PSA less than 20 ng ml−1 Prostate Cancer and Prostatic Diseases advance online publication, March 4 2014. doi:10.1038/pcan.2014.4 Authors: S Nafie, J K Mellon, J P Dormer & M A Khan (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - March 4, 2014 Category: Urology & Nephrology Authors: S NafieJ K MellonJ P DormerM A Khan Tags: prostate cancer biopsy TRUS transperineal detection Source Type: research

Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer
enfuss & J C Tilburt (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 25, 2014 Category: Urology & Nephrology Authors: S P KimC P GrossP Y NguyenM C SmaldoneR H ThompsonN D ShahA KutikovL C HanR J KarnesJ Y ZiegenfussJ C Tilburt Tags: outcomes quality of life survey treatment recommendations Source Type: research

Left lobe of the prostate during clinical prostate cancer screening: the dark side of the gland for right-handed examiners
n & A de la Taille (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 11, 2014 Category: Urology & Nephrology Authors: G PloussardN NicolaiewP Mongiat-ArtusS TerryY AlloryF VacherotC-C AbbouF DesgrandchampsL SalomonA de la Taille Tags: biopsy detection rate clinical stage digital rectal examination Source Type: research

Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population
Kim & S C Myung (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - February 4, 2014 Category: Urology & Nephrology Authors: J J OhS-S ByunS E LeeS K HongC W JeongW S ChoiD KimH J KimS C Myung Tags: prostate CYP24A1 polymorphism cancer risk Source Type: research

ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer
tava, L Bubendorf & C Ruiz (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 28, 2014 Category: Urology & Nephrology Authors: J R GsponerM BraunV J SchebleT ZellwegerA BachmannS PernerT VlajnicM SrivastavaS-H TanA DobiI A SesterhennS SrivastavaL BubendorfC Ruiz Tags: castration resistance TMPRSS2-ERG Source Type: research

The association of tumor volume with mortality following radical prostatectomy
; S A Boorjian (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 28, 2014 Category: Urology & Nephrology Authors: J J KnoedlerR J KarnesR H ThompsonL J RangelE J BergstralhS A Boorjian Tags: tumor volume radical prostatectomy mortality risk stratification Source Type: research

The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis
p; Y Zhang (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 21, 2014 Category: Urology & Nephrology Authors: Y CuiH ZongH YanY Zhang Tags: testosterone meta-analysis randomized controlled trial Source Type: research

Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database
& S J Freedland (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 14, 2014 Category: Urology & Nephrology Authors: D M MoreiraM R CooperbergL E HowardW J AronsonC J KaneM K TerrisC L AmlingM KuchibhatlaS J Freedland Tags: disease-free survival metastasis mortality prostatectomy PSA Source Type: research

Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy
, B Lee & Z Ye (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 14, 2014 Category: Urology & Nephrology Authors: X ZengZ HuZ WangJ TaoT LuC YangB LeeZ Ye Tags: RasGRP3 recurrence prognostic factor Source Type: research

An expression signature at diagnosis to estimate prostate cancer patients’ overall survival
An expression signature at diagnosis to estimate prostate cancer patients’ overall survival Prostate Cancer and Prostatic Diseases advance online publication, January 7 2014. doi:10.1038/pcan.2013.57 Authors: Z Peng, L Skoog, H Hellborg, G Jonstam, I-L Wingmo, M Hjälm-Eriksson, U Harmenberg, G C Cedermark, K Andersson, L Ährlund-Richter, S Pramana, Y Pawitan, M Nistér, S Nilsson & C Li (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - January 7, 2014 Category: Urology & Nephrology Authors: Z PengL SkoogH HellborgG JonstamI-L WingmoM Hjälm-ErikssonU HarmenbergG C CedermarkK AnderssonL Ährlund-RichterS PramanaY PawitanM NistérS NilssonC Li Tags: overall and cancer-specific survival castration therapy embryonic stem cells gene expression signature Source Type: research

Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients
mp; J Nakayama (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 24, 2013 Category: Urology & Nephrology Authors: T KamigaitoT OkaneyaM KawakuboH ShimojoO NishizawaJ Nakayama Tags: carcinoma glycosylation prognosis prostate RNA interference Source Type: research

Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy
away & P G Febbo (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 24, 2013 Category: Urology & Nephrology Authors: E M Van AllenA FoyeN WagleW KimS L CarterA McKennaJ P SimkoL A GarrawayP G Febbo Tags: bone biopsy whole-exome sequencing genomics precision medicine Source Type: research

Robotic-assisted simple prostatectomy: a systematic review and report of a single institution case series
J K Parsons (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 10, 2013 Category: Urology & Nephrology Authors: P BanapourN PatelC J KaneS A CohenJ K Parsons Tags: robotic simple prostatectomy BPH lower urinary tract symptoms outcomes Source Type: research

Anterior tumors of the prostate: clinicopathological features and outcomes
cLeod & S A Brassell (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 3, 2013 Category: Urology & Nephrology Authors: J MygattI SesterhennI RosnerY ChenJ CullenT Morris-GoreJ BartonA DobiS SrivastavaD McLeodS A Brassell Tags: anterior zone pathological outcomes ERG Source Type: research

EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer
& S Naito (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 26, 2013 Category: Urology & Nephrology Authors: E KashiwagiM ShiotaA YokomizoJ InokuchiT UchiumiS Naito Tags: celecoxib EP2 CREB androgen receptor Source Type: research

Very-high-risk localized prostate cancer: definition and outcomes
haeffer & A E Ross (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 5, 2013 Category: Urology & Nephrology Authors: D SundiV M WangP M PierorazioM HanT J BivalacquaM W BallE S AntonarakisA W PartinE M SchaefferA E Ross Tags: high-risk prostate cancer survival metastasis Source Type: research

[-2]proPSA is an early marker for prostate cancer aggressiveness
Horninger & J Bektic (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 29, 2013 Category: Urology & Nephrology Authors: I HeideggerH KlockerE SteinerV SkradskiM LadurnerR PichlerG SchäferW HorningerJ Bektic Tags: [-2]proPSA Gleason score screening cancer aggressiveness Source Type: research

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
ns, R J Karnes & E M Schaeffer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 22, 2013 Category: Urology & Nephrology Authors: A E RossF Y FengM GhadessiN ErhoA CrisanC BuerkiD SundiA P MitraI A VergaraD J S ThompsonT J TricheE DavicioniE J BergstralhR B JenkinsR J KarnesE M Schaeffer Tags: biochemical recurrence genomic classifier prognostic models metastasis clinical validation Source Type: research

Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)
& M D Krahn (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 15, 2013 Category: Urology & Nephrology Authors: K E BremnerN MitsakakisL WilsonM D Krahn Tags: utility measures prostatic neoplasms prostate cancer index PORPUS quality of life Source Type: research

Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard
n & M Emberton (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 15, 2013 Category: Urology & Nephrology Authors: M Abd-AlazeezA KirkhamH U AhmedM AryaE AnastasiadisS C CharmanA FreemanM Emberton Tags: clinically significant disease multiparametric MRI prebiopsy template prostate mapping triage test transrectal ultrasound guided biopsy Source Type: research

Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database
rman & S J Freedland (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2013 Category: Urology & Nephrology Authors: E H AllottM R AbernL GerberC J KetoW J AronsonM K TerrisC J KaneC L AmlingM R CooperbergP G MoormanS J Freedland Tags: metformin diabetes biochemical recurrence outcomes Source Type: research

Emerging association between androgen deprivation therapy and male meningioma: significant expression of luteinizing hormone-releasing hormone receptor in male meningioma
& M K Terris (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2013 Category: Urology & Nephrology Authors: Q LiH CoulsonZ KlaassenS SharmaP RamalingamK A MosesM K Terris Tags: luteinizing hormone-releasing hormone receptor meningioma androgen deprivation therapy Source Type: research

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
cci & G L Rosner (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 8, 2013 Category: Urology & Nephrology Authors: C J PallerD OlatoyeS XieX ZhouS R DenmeadeM A EisenbergerE S AntonarakisM A CarducciG L Rosner Tags: rising PSA statistics clinical trials Source Type: research

Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer
e Bono & H I Scher (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 1, 2013 Category: Urology & Nephrology Authors: O B GoodmanT W FlaigA MolinaP F A MuldersK FizaziH SuttmannJ LiT KheohJ S de BonoH I Scher Tags: abiraterone acetate liver metastases metastatic prostate cancer survival visceral disease Source Type: research

RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients
bid & C A F Lawton (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 1, 2013 Category: Urology & Nephrology Authors: L A KachnicS L PughP TaiM SmithE GoreA B ShahA-G MartinH E KimA NabidC A F Lawton Tags: radiation therapy androgen deprivation therapy osteoporosis bone fractures Source Type: research

Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men
& V N Giri (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 24, 2013 Category: Urology & Nephrology Authors: L HughesK RuthT R RebbeckV N Giri Tags: microRNA genetic variation prostatic neoplasms African American screening Source Type: research

Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study
& S Vinker (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 24, 2013 Category: Urology & Nephrology Authors: A LustmanS NakarA D CohenS Vinker Tags: hydrophobic statins hydrophilic statins prevalence Source Type: research

Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo
& C Y Pang (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 17, 2013 Category: Urology & Nephrology Authors: S C ChiuS Y HuangS P ChenC C SuT L ChiuC Y Pang Tags: tanshinone IIA LNCaP cells ER stress apoptosis GADD153/CHOP Source Type: research

High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy
& M K Terris (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 10, 2013 Category: Urology & Nephrology Authors: Q LiL LanZ KlaassenS R ShahK A MosesM K Terris Tags: Agent Orange dioxin biochemical recurrence radical prostatectomy Source Type: research

Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial)
& M R Taha (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 10, 2013 Category: Urology & Nephrology Authors: M ElbendaryO M El-GamalM G SolimanA TawfikM R Taha Tags: acute urinary retention benign prostatic obstruction tamsulosin ketoconazole Source Type: research

Prediction of prostate cancer to urethra distance by a pretreatment nomogram: urethral thermoprotection implication in cryoablation
& C Magi-Galluzzi (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 3, 2013 Category: Urology & Nephrology Authors: M M PadilhaJ Stephen JonesK Streator SmithM ZhouE WalkerC Magi-Galluzzi Tags: urethra distance cryoablation nomogram Source Type: research

Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy
y-Willer, K Pummer & S F Shariat (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - September 3, 2013 Category: Urology & Nephrology Authors: M RiekenL A KluthE XylinasC SeitzH FajkovicP I KarakiewiczY LotanA BrigantiW LoidlT FaisonJ J CrivelliD S ScherrA BachmannA K TewariA Kautzky-WillerK PummerS F Shariat Tags: statins radical prostatectomy biochemical recurrence Source Type: research

Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer
n & M A Carducci (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 20, 2013 Category: Urology & Nephrology Authors: M T SchweizerJ LinA BlackfordA BardiaS KingA J ArmstrongM A RudekS YegnasubramanianM A Carducci Tags: disulfiram epigenetics demethylation hypomethylation Source Type: research

Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case–control studies
Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case–control studies Prostate Cancer and Prostatic Diseases advance online publication, August 20 2013. doi:10.1038/pcan.2013.27 Authors: A S Parker, D D Thiel, E Bergstralh, R E Carlson, L J Rangel, R W Joseph, N Diehl & R J Karnes (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 20, 2013 Category: Urology & Nephrology Authors: A S ParkerD D ThielE BergstralhR E CarlsonL J RangelR W JosephN DiehlR J Karnes Tags: obesity PSA aggressiveness screening Source Type: research

Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients
S J Frank & D A Kuban (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 13, 2013 Category: Urology & Nephrology Authors: J Z CerneS E McGuireS R GrantM F MunsellA K LeeR J KudchadkerS L ChoiU MahmoodK E HoffmanT J PughS J FrankD A Kuban Tags: neoadjuvant androgen deprivation therapy radiation therapy biochemical response high-risk intermediate-risk Source Type: research

SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial–mesenchymal transition in vitro
SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial–mesenchymal transition in vitro Prostate Cancer and Prostatic Diseases advance online publication, August 6 2013. doi:10.1038/pcan.2013.25 Authors: L Wang, J Zhang, X Yang, Y W Y Chang, M Qi, Z Zhou, J Zhang & B Han (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - August 6, 2013 Category: Urology & Nephrology Authors: L WangJ ZhangX YangY W Y ChangM QiZ ZhouJ ZhangB Han Tags: SOX4 epithelial–mesenchymal transition prognosis metastasis Source Type: research